医学
杜皮鲁玛
特应性皮炎
不利影响
甲氨蝶呤
皮肤病科
临床试验
硫唑嘌呤
过敏
他克莫司
药理学
内科学
疾病
免疫学
移植
作者
Hyun Jin Yim,Tiffany Jean,Peck Y. Ong
标识
DOI:10.1007/s11882-024-01145-x
摘要
Historically, systemic treatments for atopic dermatitis (AD) primarily consisted of immunosuppressive agents such as corticosteroids and Disease Modifying Antirheumatic Drugs (DMARDS), which provided symptomatic relief but often had long-term adverse effects. Newer treatments have shown significant efficacy with less side effects in clinical trials. This review discusses and compares conventional and newer systemic treatments for AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI